Biotech Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm July 23, 2026
Biotech argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update July 22, 2026
Biotech Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom July 22, 2026
Biotech Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock July 21, 2026
Biotech Vivoryon Therapeutics N.V. to Report H1 2026 Financial Results and Business Updates on August 6, 2026; Annual General Meeting Planned for End of September 2026 July 21, 2026
Biotech ZYUS Announces Database Lock for its Phase 2a UTOPIA-1 Trial, CFO Transition and Continuous Disclosure Update July 20, 2026